Provided by Tiger Fintech (Singapore) Pte. Ltd.

Insulet

268.32
+2.931.10%
Post-market: 268.320.00000.00%19:54 EDT
Volume:1.30M
Turnover:346.05M
Market Cap:18.84B
PE:46.39
High:268.97
Open:263.47
Low:258.25
Close:265.39
Loading ...

Insulet Launches Omnipod 5 Insulin Delivery System in Australia

MT Newswires Live
·
18 Mar

Insulet Corp - Expands Omnipod 5 to Four More International Markets

THOMSON REUTERS
·
18 Mar

Insulet- Omnipod 5 Automated Insulin Delivery System Commercially Available in Australia, Launching Soon in Belgium, Canada, Switzerland

THOMSON REUTERS
·
18 Mar

Insulet Expands Omnipod® 5 to Four More International Markets

Business Wire
·
18 Mar

From Injections to Innovation – Insulet to Present Results from a Multinational Randomized Trial of Direct Transition from Multiple Daily Injections to Omnipod® 5 in Adults and Children with Type 1 Diabetes

Business Wire
·
18 Mar

Insulet CTO Mark Field Departs for New Opportunities

TIPRANKS
·
18 Mar

Insulet (NasdaqGS:PODD) Declines 12% After Earnings Reveal Net Income Decrease

Simply Wall St.
·
12 Mar

Insulet to Host Investor Day on June 5, 2025

Business Wire
·
11 Mar

Insulet Corp. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
11 Mar

Insulet (NASDAQ:PODD) shareholders YoY returns are lagging the company's 15% five-year earnings growth

Simply Wall St.
·
09 Mar

Insulet Corp. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
07 Mar

Insulet Initiated at Outperform by RBC Capital

Dow Jones
·
06 Mar

RBC Initiates Insulet at Outperform With $340 Price Target

MT Newswires Live
·
06 Mar

Insulet Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
05 Mar

Insulet’s Strategic Expansion and Competitive Edge Drive Buy Rating

TIPRANKS
·
04 Mar

Wells Fargo Sticks to Its Buy Rating for Insulet (PODD)

TIPRANKS
·
04 Mar